Olympia Tzaida

HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy

George Fountzilas, Christos Valavanis, Vassiliki Kotoula et al. · Journal of Translational Medicine · 2012 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy

Vassiliki Malamou‐Mitsi, Helen Gogas, Urania Dafni et al. · Annals of Oncology · 2006 · 51 citations · Full text

Medicine, Oncology, Breast Oncology +13

EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab

Evangelia Razis, George Pentheroudakis, George S. Rigakos et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 33 citations · Full text

Medicine, Molecular Genetics, Oncology +15

Malignant myoepithelioma of the breast: A case report and review of the literature

Maria Papazian, Ioannis Kalantzis, Georgios Galanopoulos et al. · Molecular and Clinical Oncology · 2016 · 26 citations · Full text

Veterinary Medicine, Oncology, Pathology +17

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial

Pantelis Skarlos, C. Christodoulou, Konstantine T. Kalogeras et al. · Cancer Chemotherapy and Pharmacology · 2011 · 25 citations

Medicine, Oncology, Chemotherapy +15